HMGB1 and myocardial infarction: Consistent with our previous research [9, 10], the present study demonstrated that DEX pretreatment significantly attenuated I/R-induced cardiac damage, as evidenced by decreases in short-term injury indicators including myocardial infarct size, cTnI release, myocardial apoptosis, cardiac HMGB1 expression, IL-6 and TNF-α production, as well as the improvement in long-term cardiac function at 4 weeks post-reperfusion.